129 related articles for article (PubMed ID: 36499376)
1. Validation of Promoters and Codon Optimization on CRISPR/Cas9-Engineered Jurkat Cells Stably Expressing αRep4E3 for Interfering with HIV-1 Replication.
Chupradit K; Sornsuwan K; Saiprayong K; Wattanapanitch M; Tayapiwatana C
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499376
[TBL] [Abstract][Full Text] [Related]
2. Gene Therapy with CRISPR/Cas9 Coming to Age for HIV Cure.
Soriano V
AIDS Rev; 2017; 19(3):167-172. PubMed ID: 29019352
[TBL] [Abstract][Full Text] [Related]
3. A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape.
Lebbink RJ; de Jong DC; Wolters F; Kruse EM; van Ham PM; Wiertz EJ; Nijhuis M
Sci Rep; 2017 Feb; 7():41968. PubMed ID: 28176813
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures.
Ophinni Y; Inoue M; Kotaki T; Kameoka M
Sci Rep; 2018 May; 8(1):7784. PubMed ID: 29773895
[TBL] [Abstract][Full Text] [Related]
5. Gene Editing in Human Lymphoid Cells: Role for Donor DNA, Type of Genomic Nuclease and Cell Selection Method.
Zotova A; Lopatukhina E; Filatov A; Khaitov M; Mazurov D
Viruses; 2017 Nov; 9(11):. PubMed ID: 29099045
[TBL] [Abstract][Full Text] [Related]
6. Differential Transgene Silencing of Myeloid-Specific Promoters in the
Klatt D; Cheng E; Hoffmann D; Santilli G; Thrasher AJ; Brendel C; Schambach A
Hum Gene Ther; 2020 Feb; 31(3-4):199-210. PubMed ID: 31773990
[TBL] [Abstract][Full Text] [Related]
7. Alpha-helicoidal HEAT-like Repeat Proteins (αRep) Selected as Interactors of HIV-1 Nucleocapsid Negatively Interfere with Viral Genome Packaging and Virus Maturation.
Hadpech S; Nangola S; Chupradit K; Fanhchaksai K; Furnon W; Urvoas A; Valerio-Lepiniec M; Minard P; Boulanger P; Hong SS; Tayapiwatana C
Sci Rep; 2017 Nov; 7(1):16335. PubMed ID: 29180782
[TBL] [Abstract][Full Text] [Related]
8. Elimination of HIV-1 Genomes from Human T-lymphoid Cells by CRISPR/Cas9 Gene Editing.
Kaminski R; Chen Y; Fischer T; Tedaldi E; Napoli A; Zhang Y; Karn J; Hu W; Khalili K
Sci Rep; 2016 Mar; 6():22555. PubMed ID: 26939770
[TBL] [Abstract][Full Text] [Related]
9. The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA.
Zhu W; Lei R; Le Duff Y; Li J; Guo F; Wainberg MA; Liang C
Retrovirology; 2015 Feb; 12():22. PubMed ID: 25808449
[TBL] [Abstract][Full Text] [Related]
10. Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection.
Wang Q; Chen S; Xiao Q; Liu Z; Liu S; Hou P; Zhou L; Hou W; Ho W; Li C; Wu L; Guo D
Retrovirology; 2017 Nov; 14(1):51. PubMed ID: 29141633
[TBL] [Abstract][Full Text] [Related]
11. Negative Feedback Regulation of HIV-1 by Gene Editing Strategy.
Kaminski R; Chen Y; Salkind J; Bella R; Young WB; Ferrante P; Karn J; Malcolm T; Hu W; Khalili K
Sci Rep; 2016 Aug; 6():31527. PubMed ID: 27528385
[TBL] [Abstract][Full Text] [Related]
12. Transient CRISPR-Cas Treatment Can Prevent Reactivation of HIV-1 Replication in a Latently Infected T-Cell Line.
Liu Y; Jeeninga RE; Klaver B; Berkhout B; Das AT
Viruses; 2021 Dec; 13(12):. PubMed ID: 34960730
[TBL] [Abstract][Full Text] [Related]
13. Targeted genome engineering in human induced pluripotent stem cells from patients with hemophilia B using the CRISPR-Cas9 system.
Lyu C; Shen J; Wang R; Gu H; Zhang J; Xue F; Liu X; Liu W; Fu R; Zhang L; Li H; Zhang X; Cheng T; Yang R; Zhang L
Stem Cell Res Ther; 2018 Apr; 9(1):92. PubMed ID: 29625575
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Genomic Safe Harbors as Target Sites for Stable Expression of the Heterologous Gene in HEK293 Cells.
Shin S; Kim SH; Shin SW; Grav LM; Pedersen LE; Lee JS; Lee GM
ACS Synth Biol; 2020 Jun; 9(6):1263-1269. PubMed ID: 32470292
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor.
Passos V; Zillinger T; Casartelli N; Wachs AS; Xu S; Malassa A; Steppich K; Schilling H; Franz S; Todt D; Steinmann E; Sutter K; Dittmer U; Bohne J; Schwartz O; Barchet W; Goffinet C
J Virol; 2019 Dec; 93(24):. PubMed ID: 31597782
[TBL] [Abstract][Full Text] [Related]
16. Elimination of infectious HIV DNA by CRISPR-Cas9.
Das AT; Binda CS; Berkhout B
Curr Opin Virol; 2019 Oct; 38():81-88. PubMed ID: 31450074
[TBL] [Abstract][Full Text] [Related]
17. Shutdown of HIV-1 Transcription in T Cells by Nullbasic, a Mutant Tat Protein.
Jin H; Li D; Sivakumaran H; Lor M; Rustanti L; Cloonan N; Wani S; Harrich D
mBio; 2016 Jul; 7(4):. PubMed ID: 27381288
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 Lethality and Loss of Env Protein Expression Induced by Single Synonymous Substitutions in the Virus Genome Intronic-Splicing Silencer.
Jordan-Paiz A; Nevot M; Lamkiewicz K; Lataretu M; Franco S; Marz M; Martinez MA
J Virol; 2020 Oct; 94(21):. PubMed ID: 32817222
[TBL] [Abstract][Full Text] [Related]
19. Characterization of promoters for adeno-associated virus mediated efficient Cas9 activation in adult Cas9 knock-in murine cochleae.
Zhao X; Jin C; Dong T; Sun Z; Zheng X; Feng B; Cheng Z; Li X; Tao Y; Wu H
Hear Res; 2020 Sep; 394():107999. PubMed ID: 32611519
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9-Derived Mutations Both Inhibit HIV-1 Replication and Accelerate Viral Escape.
Wang Z; Pan Q; Gendron P; Zhu W; Guo F; Cen S; Wainberg MA; Liang C
Cell Rep; 2016 Apr; 15(3):481-489. PubMed ID: 27068471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
